Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Cd2+ Block and Permeation of CaV3.1 (α1G) T-Type Calcium Channels: Candidate Mechanism for Cd2+ Influx

Kyle V. Lopin, Frank Thévenod, Jessica C. Page and Stephen W. Jones
Molecular Pharmacology December 2012, 82 (6) 1183-1193; DOI: https://doi.org/10.1124/mol.112.080176
Kyle V. Lopin
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio (K.V.L., S.W.J.); Center for Biomedical Research and Education, Institute for Physiology and Pathophysiology, Witten/Herdecke University, Witten, Germany (F.T.); and University of Buffalo, Buffalo, New York (J.C.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Thévenod
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio (K.V.L., S.W.J.); Center for Biomedical Research and Education, Institute for Physiology and Pathophysiology, Witten/Herdecke University, Witten, Germany (F.T.); and University of Buffalo, Buffalo, New York (J.C.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica C. Page
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio (K.V.L., S.W.J.); Center for Biomedical Research and Education, Institute for Physiology and Pathophysiology, Witten/Herdecke University, Witten, Germany (F.T.); and University of Buffalo, Buffalo, New York (J.C.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen W. Jones
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio (K.V.L., S.W.J.); Center for Biomedical Research and Education, Institute for Physiology and Pathophysiology, Witten/Herdecke University, Witten, Germany (F.T.); and University of Buffalo, Buffalo, New York (J.C.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 82 no. 6 1183-1193
DOI 
https://doi.org/10.1124/mol.112.080176
PubMed 
22973059

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 22, 2012
  • Accepted September 11, 2012
  • Published online November 14, 2012.

Article Versions

  • Earlier version (September 12, 2012 - 11:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kyle V. Lopin,
  2. Frank Thévenod,
  3. Jessica C. Page, and
  4. Stephen W. Jones
  1. Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio (K.V.L., S.W.J.); Center for Biomedical Research and Education, Institute for Physiology and Pathophysiology, Witten/Herdecke University, Witten, Germany (F.T.); and University of Buffalo, Buffalo, New York (J.C.P.)
  1. Address correspondence to:
    Stephen W. Jones, Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106. E-mail: swj{at}case.edu
  1. K.V.L. and F.T. contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2012 to January 2023

AbstractFullPdf
Sep 2012110036
Oct 201260035
Nov 2012256933
Dec 2012196525
Jan 2013117713
Feb 20136453
Mar 20133251
Apr 20134963
May 20132889
Jun 20132533
Jul 201352912
Aug 20131712
Sep 20133130
Oct 20131885
Nov 20132001
Dec 20131445
Jan 20141367
Feb 20141888
Mar 2014191121
Apr 2014141016
May 2014867
Jun 20141383
Jul 20141443
Aug 20147175
Sep 2014492
Oct 201422114
Nov 201412113
Dec 2014862
Jan 2015141157
Feb 2015797
Mar 201591310
Apr 20159349
May 20151597
Jun 2015950
Jul 2015142016
Aug 201513103
Sep 201551912
Oct 201514116
Nov 2015571
Dec 20157102
Jan 2016993
Feb 201651211
Mar 201681517
Apr 2016869
May 20168718
Jun 20161175
Jul 20168163
Aug 20161274
Sep 201613133
Oct 20167276
Nov 201661155
Dec 201601331
Jan 20170657
Feb 20170203
Mar 20170263
Apr 20170275
May 20170219
Jun 20171176
Jul 20173104
Aug 20171143
Sep 20170164
Oct 20170107
Nov 20170218
Dec 201712229
Jan 20183292
Feb 20180254
Mar 20180174
Apr 20181294
May 20181194
Jun 20180256
Jul 20181185
Aug 20180244
Sep 20180303
Oct 201807913
Nov 201809910
Dec 201868234
Jan 20195612
Feb 20195232
Mar 20192711
Apr 20191935
May 2019930
Jun 20191239
Jul 20191412
Aug 20192410
Sep 2019912
Oct 20191322
Nov 20191451
Dec 20191611
Jan 20201561
Feb 202015101
Mar 20202532
Apr 20203721
May 20203001
Jun 2020601
Jul 20201431
Aug 2020820
Sep 20201910
Oct 20201023
Nov 20201411
Dec 20201521
Jan 20211931
Feb 20212215
Mar 20213101
Apr 2021620
May 20212932
Jun 20211243
Jul 2021712
Aug 2021622
Sep 2021810
Oct 2021931
Nov 20211376
Dec 20212000
Jan 20222921
Feb 2022832
Mar 20221010
Apr 20221401
May 20222030
Jun 20221810
Jul 20221712
Aug 20222031
Sep 20221220
Oct 202211101
Nov 20221100
Dec 2022710
Jan 20231420

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 82 (6)
Molecular Pharmacology
Vol. 82, Issue 6
1 Dec 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cd2+ Block and Permeation of CaV3.1 (α1G) T-Type Calcium Channels: Candidate Mechanism for Cd2+ Influx
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cd2+ Block and Permeation of CaV3.1 T-Type Calcium Channels

Kyle V. Lopin, Frank Thévenod, Jessica C. Page and Stephen W. Jones
Molecular Pharmacology December 1, 2012, 82 (6) 1183-1193; DOI: https://doi.org/10.1124/mol.112.080176

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Cd2+ Block and Permeation of CaV3.1 T-Type Calcium Channels

Kyle V. Lopin, Frank Thévenod, Jessica C. Page and Stephen W. Jones
Molecular Pharmacology December 1, 2012, 82 (6) 1183-1193; DOI: https://doi.org/10.1124/mol.112.080176
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics